Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2019

View Archived Issues

After stroke, neurons grow up too fast

Inhibitory T cells can yield antitumor targeting

New locus found to be tied to erectile dysfunction

Synergistic effect seen for AOA-2, an ompA inhibitor, and colistin against A. baumannii

Bioharmony and Boehringer collaborate to advance bacteriophage lysins for MDR bacterial infections

Pediatric phase III study of Ragwitek sublingual allergy immunotherapy meets primary endpoint

Complutense University of Madrid, University of Santiago de Compostela patent DRD1 PAMs

Deubiquitylating enzyme inhibitors discovered at Mission Therapeutics

Shanghai Institute of Materia Medica describes new antibacterials

Novel irreversible covalent inhibitor of KRAS-G12C demonstrates efficacy in vivo

Abbisko Therapeutics discloses new CSF-1R inhibitors

KCB-3602 demonstrates potential anticancer activity in vitro

New COMT inhibitors described by the Sorbonne and collaborators

In situ-formed therapeutic gel inhibits recurrence at resection site and systemic tumor development

Anti-SIRT1 autoantibodies as a marker for ankylosing spondylitis diagnosis

Muscular Dystrophy Association grant supports AcuraStem's preclinical development of AS-2015 for ALS

TAMs boost tumor hypoxia and aerobic glycolysis

Linzess approved in China for IBS with constipation

Onstryv approved in Canada for Parkinson's disease

Knopp Biosciences expands dexpramipexole research collaboration with Cincinnati Children's Hospital

RaQualia Pharma presents sodiuim ion channel Nav1.7/Nav1.8 blockers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...